Pleural fluid carcinoembryonic antigen as a biomarker for the discrimination of tumor‐related pleural effusion
暂无分享,去创建一个
N. Zhong | liyan Huang | Huiling Li | Hailing Tang | Jianhang He | J. He
[1] Zhenxing Jiang,et al. Elevated serum C‐reactive protein, carcinoembryonic antigen and N2 disease are poor prognostic indicators in non‐small cell lung cancer , 2015, Asia-Pacific journal of clinical oncology.
[2] Li-ke Yu,et al. Diagnostic value of soluble receptor‐binding cancer antigen expressed on SiSo cells and carcinoembryonic antigen in malignant pleural effusion in patients with lung cancer , 2015, Asia-Pacific journal of clinical oncology.
[3] Maoshui Wang,et al. CEA, AFP, CA125, CA153 and CA199 in malignant pleural effusions predict the cause. , 2014, Asian Pacific journal of cancer prevention : APJCP.
[4] P. Zhan,et al. Diagnostic value of pleural interleukin 17 and carcinoembryonic antigen in lung cancer patients with malignant pleural effusions , 2014, Tumor Biology.
[5] J. M. Porcel,et al. Pearls and myths in pleural fluid analysis , 2011, Respirology.
[6] Hai‐Bo Yang,et al. Diagnostic value of carcinoembryonic antigen in malignant pleural effusion: A meta‐analysis , 2008, Respirology.
[7] R. Dweik,et al. Diagnosis and Management of Pleural Effusions: A Practical Approach , 2007, Comprehensive therapy.
[8] Kan Zhai,et al. Diagnostic accuracy of tumor markers for malignant pleural effusion: a , 2007 .
[9] S. Sahn. Pleural effusions of extravascular origin. , 2006, Clinics in chest medicine.
[10] J. M. Porcel,et al. Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions. , 2004, Chest.
[11] A. Tarn,et al. BTS guidelines for investigation of unilateral pleural effusion in adults. , 2004, Thorax.
[12] J. M. Porcel,et al. Etiology and pleural fluid characteristics of large and massive effusions. , 2003, Chest.
[13] V. Villena,et al. Diagnostic value of CA 549 in pleural fluid. Comparison with CEA, CA 15.3 and CA 72.4. , 2003, Lung cancer.
[14] N. Maskell,et al. BTS guidelines for the investigation of a unilateral pleural effusion in adults , 2003 .
[15] H. Colt,et al. Predicting survival in patients with recurrent symptomatic malignant pleural effusions: an assessment of the prognostic values of physiologic, morphologic, and quality of life measures of extent of disease. , 2000, Chest.
[16] E. Felip,et al. Diagnostic utility of CYFRA 21‐1, carcinoembryonic antigen, CA 125, neuron specific enolase, and squamous cell antigen level determinations in the serum and pleural fluid of patients with pleural effusions , 1999, Cancer.
[17] R. Light. Pleural diseases. , 1992, Disease-a-month : DM.
[18] R. G. Fraser. DIAGNOSIS OF DISEASES OF THE CHEST , 1978, The Ulster Medical Journal.
[19] G. Pescetti,et al. [Pleural effusions]. , 1965, Aggiornamenti clinicoterapeutici.